Jurnal Farmasi dan Ilmu Kefarmasian Indonesia (JFIKI) P-ISSN: 2406-9388; E-ISSN: 2580-8303 is an official journal published by the Faculty of Pharmacy, Universitas Airlangga in collaboration with Indonesian Pharmacists Association (IAI) of East Java and Center of Excellence for Patient Safety and Quality which the articles can be accessed and downloaded online by the public (open access journal).

This journal  is a unique publication that covers a wide range of topics related to pharmacy and pharmaceutical sciences research and practice. Here are some of the special features of this journal:

Focus on pharmacy and pharmaceutical sciences research and practice: The journal focuses on pharmacy and pharmaceutical sciences, specifically in Asian countries, which is a unique context with its challenges and opportunities. This allows the journal to provide insights and solutions that are specific to the Asian context.
Accessibility. The journal offers open access, meaning that anyone can freely access its articles. This is crucial for disseminating the sharing of knowledge and doing research to a broader audience.
Peer evaluation. The journal undergoes a peer review process, ensuring that field experts thoroughly assess articles before publication. This guarantees high-quality content that adheres to standards.
Interdisciplinary focus. The journal encompasses a range of topics within pharmacy and pharmaceutical sciences, including pharmacology, pharmaceutics, pharmaceutical chemistry and pharmacy practice. By adopting this approach, the journal provides an overview of the field.
Relevance to current issues. The journal publishes articles that directly address issues in pharmacy and pharmaceutical sciences in Indonesia and other Asian countries. For instance, recent publications have examined subjects such as the impact of COVID-19 on community pharmacists in Indonesia and the significance of pharmacist services in enhancing medication adherence among patients in Indonesia.

Finally, Jurnal Farmasi dan Ilmu Kefarmasian Indonesia is a one-of-a-kind publication that offers perspectives and solutions for the field of pharmacy and pharmaceutical sciences in Indonesia and Asian countries. Its emphasis on the context commitment to open access, rigorous article review process, interdisciplinary approach and relevance to current topics make it an invaluable resource for researchers, professionals and policymakers in this field.

JFIKI receives manuscript from the results of research (research article), systematic reviews and meta analysis that are closely related to the health sector, particularly the pharmaceutical field. Selected manuscripts for publication in JFIKI will be sent to two reviewers expert in their field, who are not affiliated with the same institution as the author(s), and are chosen based on the consideration of the editorial team. The review process is conducted in a closed manner where the author(s) and reviewers do not know the identity and affiliation of each. Each manuscript delegated to editorial members is examined for the final decision of the review process. The author(s) are required to respond to the review given and send revised manuscripts within the allotted time after the comments and suggestions from the reviewers have been sent. Manuscripts accepted for publication are edited copies checked for the grammar, punctuation, print style, and format. The entire process of submitting the manuscripts to the final decision for publishing is done online.